1-2 of 2
Sanjeet S Dadwal, MD
Close
Sort by
Journal Articles

Clinical Outcomes of Patients with Secondary Acute Myeloid Leukemia (sAML) Treated with Hypomethylating Agent Plus Venetoclax (HMA-Ven) or Liposomal Daunorubicin Cytarabine (CPX-351)

Amandeep Salhotra, MD, Dat Ngo, PharmD, Jianying Zhang, Karamjeet S. Sandhu, MD, Monzr M. Al Malki, MD, Ahmed Aribi, MD, Haris Ali, MD, Pkoller Koller, MD, Shukaib Arslan, MD, Andrew S. Artz, MD, Lihua E Budde, MD PhD, Samer Khaled, MD, Sanjeet S Dadwal, MD, David S Snyder, MD, Stephen J. Forman, MD, Ryotaro Nakamura, MD, Anthony S. Stein, MD, Guido Marcucci, MD, Ibrahim Aldoss, MD, Vinod A. Pullarkat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-140538
Published: 2020
Journal Articles

Healthcare Resource Utilization in Transplant Patients Who Are at a Higher-Risk to Develop Cytomegalovirus Infection during Their Primary Transplant-Related Hospitalization

Sanjeet S Dadwal, MD, Dongyun Yang, PhD, Bernard Tegtmeier, Vinod A. Pullarkat, MD, Sally Mokhtari, PhD, Joycelynne Palmer, PhD, Jana Dickter, MD, John Zaia, MD, David S Snyder, MD, Deepa Nanayakkara, MD, Amandeep Salhotra, MD, Alfredo Puing, MD, Ricardo Spielberger, MD, Karamjeet S. Sandhu, MD, Anthony S. Stein, MD, Randy Taplitz, MD, Eileen P. Smith, MD, Stephen J. Forman, MD, Monzr M. Al Malki, MD, Ryotaro Nakamura, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-143452
Published: 2020